What you're doing is a specific case of a general process -- determining a substance's photo-decomposition. There is a defined method for the this specific procedure according to NIST, and a pharmaceutical would be required to follow it according to USP (EUP, JP, RP whatever) regulations. You can look it up, but to generally describe it:
Your sample and a standardized sample of quinine would be exposed side by side to a calibrated light source for varying periods of time. It is known that quinine decomposes and loses it absorbance at it's own max wavelength at a certain rate on exposure to light. You can compare the rate at which your sample degrades to the rate quinine degrades to make a determination as to how light unstable you sample is, for USP purposes.
Now, if you're not trying to submit your sample for FDA approval, you don't have to be that rigid. However, you can use the same idea: you purchase a broad spectrum lamp that is calibrated with a certain light output, and/or you monitor its output with a light meter (preferable, since all light sources wear out over time.) You expose your sample and a sample of quinine, to see how the sample behaves over time relative to the quinine. You of course need a control for both, a sample of your product and quinine that is wrapped in foil or black cardboard, because focusing a light on a sample is also going to cause thermal decomposition apart from the photo-decomposition. But you can find the complete FDA protocol online, and adapt it to your needs.